Evaluate the Safety and Efficacy of CD33 CAR-T in Patients With R/R AML

NCT05473221 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Zhejiang University